Chair’s Opening Remarks
Time: 8:30 am
day: Day One
Details:
Overview as to why RNA Editing is presently reaching an inflection point and the applications that the industry believes RNA Editing could tackle.
Speakers:
Andrew Fraley, a founder of Korro Bio, serves as SVP of Technology. Andrew brings over 20 years of experience in the field of nucleic acid technologies and therapeutics. A scientist and entrepreneur at heart, he has founded biotech companies including Triplet Therapeutics, Korro Bio and Trucode Gene Repair, and additionally functions as an Entrepreneur for…Read more